Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :29997569
Publication Date : //

Reframing the Biological Basis of Neuroprotection Using Functional Genomics: Differentially Weighted, Time-Dependent Multifactor Pathogenesis of Human Ischemic Brain Damage.


Neuroprotection studies are generally unable to demonstrate efficacy in humans. Our specific hypothesis is that multiple pathophysiologic pathways, of variable importance, contribute to ischemic brain damage. As a corollary to this, we discuss the broad hypothesis that a multifaceted approach will improve the probability of efficacious neuroprotection. But to properly test this hypothesis the nature and importance of the multiple contributing pathways needs elucidation. Our aim is to demonstrate, using functional genomics, in human cardiac surgery procedures associated with cerebral ischemia, that the pathogenesis of perioperative human ischemic brain damage involves the function of multiple variably weighted proteins involving several pathways. We then use these data and literature to develop a proposal for rational design of human neuroprotection protocols. Ninety-four patients undergoing deep hypothermic circulatory arrest (DHCA) and/or aortic valve replacement surgery had brain damage biomarkers, S100β and neurofilament H (NFH), assessed at baseline, 1 and 24 h post-cardiopulmonary bypass (CPB) with analysis for association with 92 single nucleotide polymorphisms (SNPs) (selected by co-author WAK) related to important proteins involved in pathogenesis of cerebral ischemia. At the nominal significance level of 0.05, changes in S100β and in NFH at 1 and 24 h post-CPB were associated with multiple SNPs involving several prospectively determined pathophysiologic pathways, but were not individually significant after multiple comparison adjustments. Variable weights for the several evaluated SNPs are apparent on regression analysis and, notably, are dissimilar related to the two biomarkers and over time post CPB. Based on our step-wise regression model, at 1 h post-CPB, SOD2, SUMO4, and GP6 are related to relative change of NFH while TNF, CAPN10, NPPB, and SERPINE1 are related to the relative change of S100B. At 24 h post-CPB, ADRA2A, SELE, and BAX are related to the relative change of NFH while SLC4A7, HSPA1B, and FGA are related to S100B. In support of the proposed hypothesis, association SNP data suggest function of specific disparate proteins, as reflected by genetic variation, may be more important than others with variation at different post-insult times after human brain ischemia. Such information may support rational design of post-insult time-sensitive multifaceted neuroprotective therapies.

Authors : Kofke William A , Ren Yue , Augoustides John G , Li Hongzhe , Nathanson Katherine , Siman Robert , Meng Qing Cheng , Bu Weiming , Yandrawatthana Sukanya , Kositratna Guy , Kim Cecilia , Bavaria Joseph E ,

Related products :

Catalog number Product name Quantity
EIAAB37902 Homo sapiens,Human,KIAA1253,SERINC1,Serine incorporator 1,TDE1L,TDE2,Tumor differentially expressed protein 1-like,Tumor differentially expressed protein 2,UNQ396_PRO732
DD2 Real-time PCR DNA Quantitation after QPCR DNA Damage Analysis Kit
DD2 Real-time PCR DNA Quantitation after QPCR DNA Damage Analysis Kit
SGB-1 Protein Crystallization Strategies for Structural Genomics (SGB-1)
YGPM10 Genomics DNA Extraction Maxi Kit (Plant) 10 preps GP1 Buffer x 50ml GPX1 Buffer x 50ml GP2 Buffer x 15ml GP3 Buffer(Concentrated) x 30ml W1 Buffer x 5
EIAAB37901 Aigp2,Axotomy-induced glyco_Golgi protein 2,Membrane protein TMS-2,Mouse,Mus musculus,Serinc1,Serine incorporator 1,Tde1l,Tde2,Tms2,Tumor differentially expressed protein 1-like,Tumor differentially e
EIAAB10707 Damage-specific DNA-binding protein 1,DDB p127 subunit,DDB1,DDBa,DNA damage-binding protein 1,DNA damage-binding protein a,HBV X-associated protein 1,Homo sapiens,Human,UV-damaged DNA-binding factor,U
EIAAB37903 Rat,Rattus norvegicus,Serinc1,Serine incorporator 1,Tde1l,Tde2,Tumor differentially expressed protein 1-like,Tumor differentially expressed protein 2
32-172 p16 (cyclin-dependent kinase inhibitor 2A, INK4a) is a tumor suppressor protein. It is a specific inhibitor of Cdk 4 _ Cdk 6, and a tumor suppressor involved in the pathogenesis of a variety of malign 0.1 mL
45-339P Brain Creatine Kinase Peptide Please note that this peptide has a delivery time of approximately 3 weeks. If the peptide is out of stock, the delivery time may take up to 1-3 months. 0.1 mg
5219 Myocardial ischemic preconditioning upregulated protein 1 0.5 mg
5219 Myocardial ischemic preconditioning upregulated protein 1 0.1 mg
27-938 Poly (ADP-ribosyl)ation is an immediate DNA-damage-dependent post-translational modification of histones and other nuclear proteins that contributes to the survival of injured proliferating cells. PAR 0.05 mg
25-157 Poly (ADP-ribosyl)ation is an immediate DNA-damage-dependent post-translational modification of histones and other nuclear proteins that contributes to the survival of injured proliferating cells. PAR 0.05 mg
27-942 Poly (ADP-ribose) polymerases (PARPs) constitute a large family of 18 proteins, encoded by different genes and displaying a conserved catalytic domain. They are involved in DNA-damage-dependent post-t 0.1 mg
27-997 Poly (ADP-ribose) polymerases (PARPs) constitute a large family of 18 proteins, encoded by different genes and displaying a conserved catalytic domain. They are involved in DNA-damage-dependent post-t 0.05 mg
EIAAB10743 DDIT4L,DNA damage-inducible transcript 4-like protein,HIF-1 responsive protein RTP801-like,Homo sapiens,Human,Protein regulated in development and DNA damage response 2,REDD2,REDD-2,RTP801L
28-271 The CLCN family of voltage-dependent chloride channel genes comprises nine members (CLCN1-7, Ka and Kb) which demonstrate quite diverse functional characteristics while sharing significant sequence ho 0.1 mg
EIAAB46159 CDW2,CUL4- and DDB1-associated WDR protein 2,Homo sapiens,Human,MIP2,Myocardial ischemic preconditioning up-regulated protein 2,PRO0852,WD repeat-containing protein 26,WDR26
RPR-550 Recombinant Human GLI Pathogenesis-Related 2 5
pro-550 Recombinant Human GLI Pathogenesis-Related 2 5
pro-550 Recombinant Human GLI Pathogenesis-Related 2 1mg
pro-550 Recombinant Human GLI Pathogenesis-Related 2 25
pro-550 Recombinant Human GLI Pathogenesis-Related 2 GLIPR2 25
OETPRO550 GLI Pathogenesis-Related 2 Human Recimbinant 25


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur